drug-supply
Every record this desk has filed under drug-supply, newest first, each with the number of sources it can still show you.
OMB reopens essential-medicine manufacturing responses through November 27, with online submissions required
An OMB notice scheduled for Federal Register publication November 2 reopens an essential-medicine manufacturing inquiry through November 27. It seeks information about new and unused domestic and near-shore production capabilities associated with the ASPR 86 List. Responses must go through Regulations.gov; the notice is not a procurement promise, funding award or finding that production capacity has increased.
Also filed underessential-medicinesmanufacturingpublic-commentsombfederal-register
A record appears here because it carries drug-supply in its own tags. If a record you expected is missing, it was filed under a different subject — the full list is on the topics index.